BMO Expects Canadian Banks To Outperform In 2021

In a note sent out to investors on January 3rd, BMO Capital Markets headlines “Bank Index Underperforms Again in 2020; History Suggests Outperformance in 2021.”

Sohrab Movahedi, BMO Capital Markets Canadian bank analyst, predicts that the basket of Canadian banks will outperform in 2021 after lagging behind the S&P and TSX for the second consecutive year. The Canadian bank index ended up 3.6% in 2020, while the median total return of 45 bank stocks was roughly -12%.

Movahedi writes, “since 1970, there have been three instances when the bank index underperformed the composite in consecutive years, and in each case, the banks outperformed the following year by an average of 780 bps.”

Movahedi believes this could be achieved through a multitude of paths such as earnings growth, dividend yield, and some multiple expansions and specifically identifies Bank of Nova Scotia and CIBC as the top winners. Movahedi adds that for investors who like to take the contrarian approach, they should be looking at the Canadian banks. Specifically, Bank of Nova Scotia, BMO, and National Bank of Canada over TD, Royal Bank, and CIBC.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Among the big six, CIBC was the best performer with a 7% return throughout the last year. On the flip side Laurentian was the worst performer for 2020, with a decline of 25.2%.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Building the $500M-a-Year Gold Mine | Victor Cantore – Amex Gold Mining

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

New Gold: BMO Cuts Price Target Significantly After Guidance Revisions

On Monday New Gold (TSX: NGD) reported its second quarter production results. The company produced...

Wednesday, July 13, 2022, 12:24:00 PM

Aurora Cannabis: Analysts Slash Price Targets Ahead Of Q4 Earnings

Tomorrow after market close Aurora Cannabis (TSX: ACB) (NYSE: ACB) will be reporting their fiscal...

Monday, September 21, 2020, 03:15:54 PM

IAMGOLD: BMO Lowers Target Due To “Unknown Unknowns”

On October 18th, IAMGOLD Corp (TSX: IMG) filed their third quarter updates. The company reported...

Monday, November 1, 2021, 05:24:00 PM

Roku: Analysts Expect Positive Net Income For Q2 2021

Roku Inc (NASDAQ: ROKU) will be reporting its second quarter financial results after the market...

Wednesday, August 4, 2021, 03:10:00 PM

Square: Consensus Price Target Climbs To $290 Following AfterPay Purchase

On August 2, a Sunday, Square Inc (NYSE: SQ) announced that they would be acquiring...

Tuesday, August 3, 2021, 12:44:00 PM